InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INM InMed Pharmaceuticals Inc

已收盘 11-26 16:00:00 EST

4.53

+0.03

+0.67%

盘后4.55

+0.02+0.44%

19:24 EST

最高4.90	最低4.36	成交量2.18万
今开4.51	昨收4.50	日振幅12.00%
总市值325.27万	流通市值323.44万	总股本71.80万
成交额9.86万	换手率3.06%	流通股本71.40万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INM","market":"US","secType":"STK","nameCN":"InMed Pharmaceuticals Inc","latestPrice":4.53,"timestamp":1732654800000,"preClose":4.5,"halted":0,"volume":21848,"hourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.53,"latestTime":"19:24 EST","volume":104,"amount":473.18,"timestamp":1732667067677},"delay":0,"floatShares":714000,"shares":718032,"eps":-20.14294,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"11-26 16:00:00 EST","open":4.51,"high":4.9,"low":4.36,"amount":98593.6793408,"amplitude":0.12,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.14294,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"adjPreClose":4.5,"preHourTrading":{"tag":"盘前","latestPrice":4.48,"preClose":4.5,"latestTime":"08:00 EST","volume":1,"amount":4.48,"timestamp":1732626000372},"postHourTrading":{"tag":"盘后","latestPrice":4.55,"preClose":4.53,"latestTime":"19:24 EST","volume":104,"amount":473.18,"timestamp":1732667067677},"volumeRatio":0.509118},"requestUrl":"/m/hq/s/INM/tweets","defaultTab":"tweets","newsList":[{"id":"2485293204","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘大幅上涨6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485293204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485293204?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:06","pubTimestamp":1732291602,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时06分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速上涨6.88%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1740.86%、120.73%、87.93%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为62.35%、45.86%、38.10%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000642abd7ba5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000642abd7ba5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007","VRPX"],"gpt_icon":0},{"id":"2484170221","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘快速下挫5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484170221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484170221?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:43","pubTimestamp":1732113783,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时43分，Inmed Pharmaceuticals Inc.股票出现波动，股价急速跳水5.67%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Forte Biosciences, Inc.涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为740.85%、266.77%、132.22%，振幅较大的相关个股有Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为56.10%、43.71%、28.46%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022430395be4d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022430395be4d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2484928230","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘快速拉升7.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484928230?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026709,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅上涨7.54%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为621.62%、76.93%、63.49%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Invizyne Technologies Inc.、Tff Pharmaceuticals, Inc.，振幅分别为28.79%、23.08%、22.91%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223149971a76a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223149971a76a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2484676101","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676101?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:45","pubTimestamp":1731941147,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时45分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速下挫5.41%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Hcw Biologics Inc.、冠科美博、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为544.29%、360.02%、261.59%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为118.81%、62.38%、42.18%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224548a2433284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224548a2433284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2483045008","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大跌8.99%报4.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483045008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483045008?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:34","pubTimestamp":1731594855,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时34分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅下挫8.99%。截至发稿，该股报4.23美元/股，成交量1232股，换手率0.01%，振幅0.00%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422341698e42a24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422341698e42a24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","INM","BK4007","ELAB"],"gpt_icon":0},{"id":"2483058514","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨5.45%报0.257美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483058514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483058514?lang=zh_cn&edition=full","pubTime":"2024-11-13 03:05","pubTimestamp":1731438347,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日03时05分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速上涨5.45%。截至发稿，该股报0.257美元/股，成交量40.5241万股，换手率3.03%，振幅6.39%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113030547a2313dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113030547a2313dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2482273690","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482273690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482273690?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:21","pubTimestamp":1731338513,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时21分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速拉升5.89%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为465.33%、411.86%、130.17%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为123.43%、72.42%、40.91%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123215398e41d32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123215398e41d32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2481968890","title":"Inmed Pharmaceuticals Inc.盘中异动 急速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481968890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481968890?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:35","pubTimestamp":1730817345,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时35分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅下跌5.35%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223546aba23da8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223546aba23da8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2480581591","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘快速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581591?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730744,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.18%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为234.93%、128.40%、42.86%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.，振幅分别为29.83%、22.67%、12.78%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223224a2154988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223224a2154988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2480805310","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480805310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480805310?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:21","pubTimestamp":1730391709,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时21分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.09%。截至发稿，该股报0.278美元/股，成交量11.3088万股，换手率0.85%，振幅4.37%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为3.44%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。该公司从事新型大麻素类药物的研发和制药级大麻素的生产。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002149ab8c5ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002149ab8c5ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2477534056","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534056?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:45","pubTimestamp":1729781110,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时45分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速下跌5.69%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Viking Therapeutics, Inc.、Biovie Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为232.62%、162.68%、92.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Chromocell Therapeutics Corporation，振幅分别为62.74%、60.32%、45.03%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422451198e3e476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422451198e3e476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2477351285","title":"Inmed Pharmaceuticals Inc.盘中异动 大幅下跌5.24%报0.302美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477351285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477351285?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:54","pubTimestamp":1729691698,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时54分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.24%。截至发稿，该股报0.302美元/股，成交量26.7542万股，换手率2.01%，振幅5.05%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215458a1e40c78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215458a1e40c78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2477304883","title":"Inmed Pharmaceuticals Inc.股价飙升12.41% 市值涨15.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477304883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477304883?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:30","pubTimestamp":1729603845,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时30分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速拉升12.41%。截至发稿，该股报0.326美元/股，成交量108.922万股，换手率8.16%，振幅0.00%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213045a1e2cf23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213045a1e2cf23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2476258314","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大跌11.29%报0.220美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476258314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476258314?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:41","pubTimestamp":1729258865,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时41分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速跳水11.29%。截至发稿，该股报0.220美元/股，成交量10.0333万股，换手率0.75%，振幅13.99%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101821410598e3d43f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101821410598e3d43f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2476204231","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘急速拉升5.00%报0.240美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476204231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476204231?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:37","pubTimestamp":1729172229,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时37分，Inmed Pharmaceuticals Inc.股票出现异动，股价快速拉升5.00%。截至发稿，该股报0.240美元/股，成交量11.7127万股，换手率1.31%，振幅2.10%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213710ab6ad830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213710ab6ad830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2476194303","title":"Inmed Pharmaceuticals Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476194303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476194303?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:53","pubTimestamp":1729094009,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时53分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速上涨5.02%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6278.56%、1096.05%、844.55%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为633.55%、279.52%、146.83%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623532998e3cd1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623532998e3cd1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2475868829","title":"Inmed Pharmaceuticals Inc.盘中异动 股价大涨9.47%报0.227美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475868829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475868829?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:31","pubTimestamp":1728999101,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时31分，Inmed Pharmaceuticals Inc.股票出现波动，股价快速上涨9.47%。截至发稿，该股报0.227美元/股，成交量1.9351万股，换手率0.22%，振幅0.29%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410152131419f44e4c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410152131419f44e4c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2473093891","title":"Inmed Pharmaceuticals Inc.盘中异动 急速上涨5.34%报0.213美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473093891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473093891?lang=zh_cn&edition=full","pubTime":"2024-10-07 22:05","pubTimestamp":1728309948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日22时05分，Inmed Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.34%。截至发稿，该股报0.213美元/股，成交量3.2192万股，换手率0.36%，振幅1.78%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072205489719ea75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072205489719ea75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2472950128","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472950128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472950128?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:01","pubTimestamp":1728050514,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时01分，Inmed Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.37%。截至发稿，该股报0.206美元/股，成交量10.7837万股，换手率1.21%，振幅4.73%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。该公司从事新型大麻素类药物的研发和制药级大麻素的生产。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004220154ab67bd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004220154ab67bd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2472161592","title":"Inmed Pharmaceuticals Inc.盘中异动 早盘股价大涨8.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472161592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472161592?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:32","pubTimestamp":1727962325,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时32分，Inmed Pharmaceuticals Inc.股票出现异动，股价急速上涨8.39%。Inmed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为1795.56%、686.01%、385.09%，振幅较大的相关个股有Elevai Labs, Inc.、Theriva Biologics, Inc.、Aditxt, Inc.，振幅分别为40.49%、18.54%、13.70%。Inmed Pharmaceuticals Inc.公司简介：InMed Pharmaceuticals Inc 是一家位于加拿大的临床阶段生物制药公司。IntegraSyn 是制药级大麻素的制造系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032132059f272d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032132059f272d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","INM","BK4183","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inmedpharma.com","stockEarnings":[{"period":"1week","weight":0.0613},{"period":"1month","weight":-0.3245},{"period":"3month","weight":-0.4428},{"period":"6month","weight":-0.1964},{"period":"1year","weight":-0.4156},{"period":"ytd","weight":-0.4591}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InMed Pharmaceuticals Inc.根据不列颠哥伦比亚省商业公司法，于1981年5月19日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的制药公司，致力于开发针对医疗需求未得到满足的疾病的处方药，并开发专利制造技术。该公司正在开发一种基于生物合成的集成制造方法，称为IntegraSynTM，用于合成药物级大麻素以及多种候选产品。该公司致力于为可能受益于大麻素类药物的患者提供新的治疗替代品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005166},{"month":2,"riseRate":0.5,"avgChangeRate":-0.085756},{"month":3,"riseRate":0.25,"avgChangeRate":-0.132085},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018921},{"month":5,"riseRate":0.5,"avgChangeRate":-0.028557},{"month":6,"riseRate":0.25,"avgChangeRate":-0.179927},{"month":7,"riseRate":0.25,"avgChangeRate":-0.105641},{"month":8,"riseRate":0.25,"avgChangeRate":0.038545},{"month":9,"riseRate":0.25,"avgChangeRate":-0.144917},{"month":10,"riseRate":0.25,"avgChangeRate":-0.213206},{"month":11,"riseRate":0.25,"avgChangeRate":-0.032399},{"month":12,"riseRate":0,"avgChangeRate":-0.173492}],"exchange":"NASDAQ","name":"InMed Pharmaceuticals Inc","nameEN":"InMed Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InMed Pharmaceuticals Inc(INM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InMed Pharmaceuticals Inc,INM,InMed Pharmaceuticals Inc股票,InMed Pharmaceuticals Inc股票老虎,InMed Pharmaceuticals Inc股票老虎国际,InMed Pharmaceuticals Inc行情,InMed Pharmaceuticals Inc股票行情,InMed Pharmaceuticals Inc股价,InMed Pharmaceuticals Inc股市,InMed Pharmaceuticals Inc股票价格,InMed Pharmaceuticals Inc股票交易,InMed Pharmaceuticals Inc股票购买,InMed Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InMed Pharmaceuticals Inc(INM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}